← Open Payments lookup

DAVID RAMIN: Open Payments

NPI 1992893424 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,837 in 96 payments from 20 companies in 2025. Trend: 2023 $1,379 · 2024 $2,373 · 2025 $2,837

Food & beverage: $2,837
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP19$611
Amgen Inc.12$489
Gilead Sciences, Inc.6$246
Novo Nordisk Inc10$228
Bayer Healthcare Pharmaceuticals Inc.9$195
Axsome Therapeutics, Inc.4$120
Takeda Pharmaceuticals U.S.A., Inc.4$116
Boehringer Ingelheim Pharmaceuticals, Inc.4$114
Kowa Pharmaceuticals America, Inc.5$96
Lilly USA, LLC3$84

Products named: OTEZLA, Kerendia, Ozempic, BREZTRI, AIRSUPRA, FARXIGA, Auvelity, Yeztugo.

Industry payments across CA — which companies pay providers there.